Point-of-care creatinine testing in children at risk for sudden deterioration of renal function

Paul W Schenk1, Karlien Cransberg, Eric D Wolff

  • 1Department of Clinical Chemistry, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Point-of-care creatinine testing in children using Reflotron and i-STAT devices shows good correlation with standard assays. The i-STAT system is recommended for home monitoring due to its ease of use.

Area of Science:

  • Pediatric Nephrology
  • Clinical Chemistry
  • Biomedical Engineering

Background:

  • Point-of-care testing (POCT) for creatinine offers potential for early detection of renal function decline in pediatric patients.
  • Home-based monitoring of creatinine levels is crucial for managing recurrent conditions affecting kidney health in children.

Purpose of the Study:

  • To evaluate the performance of two point-of-care creatinine testing systems, Reflotron and i-STAT, against a standard automated assay.
  • To assess the suitability of these POCT systems for clinical use, particularly in pediatric settings.

Main Methods:

  • A comparative study involving 20 pediatric patients (2 months to 17 years).
  • Capillary blood samples were analyzed using Reflotron, i-STAT, and a Hitachi 912 automated creatinine assay.
  • Statistical analysis included mean difference and Passing-Bablok regression for method comparison.

Main Results:

  • Both Reflotron and i-STAT demonstrated good correlation with the Hitachi 912 assay.
  • Mean differences were -16 micromol/L for Reflotron and 4 micromol/L for i-STAT compared to the reference method.
  • Passing-Bablok slopes indicated strong agreement, with values of 0.95 and 0.96, respectively.

Conclusions:

  • Reflotron and i-STAT are reliable point-of-care systems for measuring blood creatinine concentrations in capillary samples.
  • Both devices perform well, especially within the creatinine concentration range up to 500 micromol/L.
  • The i-STAT system is identified as a preferable choice for home-based monitoring due to its user-friendliness.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...